跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEPHIENCE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SEPHIENCE
Authorized
STANDARD
SEPHIENCE
PTC THERAPEUTICS INTERNATIONAL LIMITED
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
cefcca8becba5b37
Company
PTC THERAPEUTICS INTERNATIONAL LIMITED
Type
Standard
Approval Details
Approval Id
cefcca8becba5b37
Drug Approval Canada Name
SEPHIENCE
Product Name
SEPHIENCE
Status
Marketed
Status Date
2025-12-01
Original Market Date
2025-12-01
Drug Class
Human
Dosage Form
Powder
Route Of Administration
Oral
Schedule
Prescription
Ahfs
44:08.00
Atc Original
A16AX28 SEPIAPTERIN
Aig Number
0167513002
Company Name
PTC THERAPEUTICS INTERNATIONAL LIMITED
Company Address
Unit 1, 52-55 Sir John Rogerson'S Quay, Dublin 2 Dublin Ireland D02 NA07
Company Detail Path
/organization/ptc-therapeutics-international-limited
Company Information
Pharmaceutical Company Name
PTC THERAPEUTICS INTERNATIONAL LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
5th Floor, 3 Grand Canal Plaza
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
cefcca8becba5b37
Type
Standard
Back to Health Canada Approvals